Please be aware that ISPE Headquarters in Tampa, Florida USA is under a hurricane watch through Thursday 29 September. We appreciate your patience during this time as we work to assist you. Please note there could be delays in response time. We will continue to do our best to provide efficient service.
In this highly interactive session, attendees will have the opportunity to explore how the thoughtful integration of Quality Risk Management (QRM) and Knowledge Management (KM) can lead to more informed decision making across the Pharmaceutical Quality System (PQS) during technology transfer and commercial manufacturing. The discussion will be led by regulatory science researchers from TU Dublin and industry experts.
A novel framework to intentionally unite QRM and KM, the Risk-Knowledge Infinity Cycle (RKI Cycle), was first introduced in May 2021 through the ISPE Good Practice Guide on Knowledge Management in the Pharmaceutical Industry and an ISPE Webinar, Exploring the RKI Cycle Across the Product Lifecycle. The RKI Cycle will be presented in brief to orient the attendees, followed by a presentation on risk-based decision making. These presentations will be followed by breakout sessions to engage with the experts and fellow participants on how they view the potential opportunity and impact of the RKI Cycle, as well as potential implementation challenges.